Last updated: May 12, 2018
Sponsor: Marjukka Kolehmainen
Overall Status: Completed
Phase
N/A
Condition
Metabolic Syndrome
Diabetes (Pediatric)
Dyslipidemia
Treatment
N/AClinical Study ID
NCT01414647
124//2005
40361/05
Ages 50-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
overweight (BMI 26-39 kg/m2), and two of the following:
elevated fasting plasma glucose in the absence of diabetes (5.6-6.9 mmol/l)
abnormal serum lipid concentration: fasting serum triglyceride concentration >1.7mmol/L, fasting serum HDL cholesterol <1.0 mmol/L (males) or <1.3 mmol/L (females))
waist circumference >102 cm (males) or >88 cm (females)
blood pressure >130/85 mmHg
Exclusion
Exclusion Criteria:
chronic diseases
use of lipid lowering medication
Study Design
Total Participants: 56
Study Start date:
January 01, 2006
Estimated Completion Date:
March 31, 2010
Study Description
Connect with a study center
University of Eastern Finland, Dpet of Public Health and Clinical Nutrition
Kuopio, FIN-70211
FinlandSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.